News Snapshot:
Everest To Introduce Canadian Biotech's Potential COVID Vax to China And Other Markets Interim data from an early-stage human trial outside China has showed Providence's shot PTX-COVID19-B was safe and produced strong antibody responses, Everest said in a statement on Monday. Everest Medicines, based in Shanghai, announced a licence agreement with Providence Therapeutics to manufacture and sell the Canadian biotechnology company's potential mRNA COVID vaccines in some Asian countries, including China. Interim data from an early-stage human trial outside China has showed Providence's shot PTX-COVID19-B was safe and produced strong antibody responses, Everest said in a statement on Monday. Messenger...
